Managed Care Best Practices in the Treatment and Management of Non-Small Cell Lung Cancer

Lung cancer is the most prevalent form of cancer-related mortality in adults. Because the diagnosis of lung cancer at an advanced stage generally has a poor prognosis, lung cancer must be diagnosed early and treatment options must be expanded. Non-small cell lung cancer (NSCLC) accounts for 80 percent of all cases and has been treated through chemotherapy, radiation therapy, combined chemoradiotherapy, and surgery. Increasingly, combining emerging biologic and experimental therapies with conventional treatments holds the potential for favorable outcomes. This supplement summarizes the growing number of treatment options available.


  • Non-Small Cell Lung Cancer – an Overview
  • Outlook for Non-Small Cell Lung Cancer Treatment
  • Treatment Options – a Medical Director’s Perspective

Panel Discussions:

  • Improving Survival and Quality of Life
  • Benefit and Reimbursement Structures for Oncologics
  • Fostering Appropriate Use of Oncologics